Sunovion Pharmaceuticals Inc. (United States)

Sunovion Pharmaceuticals, part of Sumitomo Pharma America, develops and commercializes treatments for CNS and respiratory diseases. Key products include Latuda (lurasidone) for schizophrenia and bipolar depression, Kynmobi for Parkinson’s disease, and respiratory medications including Brovana and Perforomist for COPD. Sunovion’s neuroscience and pulmonary expertise addresses serious chronic conditions.